#medrxiv — Public Fediverse posts

#OpenRxiv just added an #AI #PeerReview feature for #preprints on #bioRxiv and #medRxiv. At the moment, they're using the #qedscience tool.
https://www.nature.com/articles/d41586-025-03909-5

The bioRxiv announcement makes clear that AI review is optional for authors and that authors might be able to choose from other AI tools in the future.
https://connect.biorxiv.org/news/2025/11/04/qed_review_tool

PS: My experiments lead me to think that AI isn't good enough to do peer review yet -- even if (1) it's getting better, (2) it can already help human reviewers, and (3) many human reviewers are worse. Journals that allow it too large a role are abdicating their responsibility and might be deceiving authors and readers. Referees who give it too large a role are abdicating their responsibility and might be deceiving journals, authors, and readers. If you lean in the same direction, let me suggest that these objections don't carry over to preprint servers making AI review an #FWIW option for authors. This kind of AI review doesn't pretend to be more than it is. When it happens, it's a voluntary decision by authors. Of course authors could have gotten AI feedback on their own, with the AI tools of their choice, and without the preprint-server mediation. But giving them another option for the same kind of feedback is harmless and convenient. Moreover, it creates a training ground to monitor the quality and improvement of the AI tools.

Light exposure at night predicts incidence of cardiovascular diseases

https://www.medrxiv.org/content/10.1101/2025.06.20.25329961v1

#HackerNews #LightExposure #NightHealth #CardiovascularResearch #SleepScience #MedRxiv

In the updated license selector, the most open Creative Commons licenses appear first, with refreshed accessible language for each license that centers the researcher and their choices. Thanks to the Chan Zuckerberg Initiative for supporting these efforts.

#OpenScience #Preprints #CreativeCommons #bioRxiv #medRxiv #OpenAccess #Research #openRxiv

Prépublications en sciences de la vie et de la santé : #bioRxiv et #medRxiv lancent #openRxiv une organisation indépendante à but non lucratif chargée de leur gouvernance
#Preprints #OpenAccess

https://www.nature.com/articles/d41586-025-00762-4

#Preprint sites #bioRxiv and #medRxiv launch new era of independence
The popular repositories, where life #scientists post research before #peerreview, will be managed by a new organization called #openRxiv.
Until now, they had been managed by Cold Spring Harbor Laboratory. The new organization, named openRxiv, will have a board of directors and a scientific and medical advisory board. It is supported by a fresh US$16M grant from Chan Zuckerberg Initiative (CZI).
https://www.nature.com/articles/d41586-025-00762-4

Interesting study on COVID contact tracing, manually, or via apps. In NL, merely 2% of the PCR tests were done after a notification originating from the Dutch tracing app (CoronaMelder), and just 2.5% after being traced manually.

The study concludes that contact tracing, digitally or manually, had little effect (“limited impacts”).

https://www.medrxiv.org/content/10.1101/2023.04.27.23289149v1

#covid19 #coronaMelder #contactTracing #medrxiv

#arXiv, @biorxivpreprint, and @medrxivpreprint have released their public comments on the the #OSTP #NelsonMemo.

From arXiv
https://info.arxiv.org/about/OSTP-04-11-2023.html

From bioRxiv and medRxiv
https://connect.biorxiv.org/news/2023/04/11/ostp_response

PS: There's a distinct echo of #Plan_U in these comments, tho without using the term. I'm glad to see it's still alive. Here's some background from 2019.
http://planu.org/

#bioRxiv, #medRxiv, #OAintheUSA, #preprints

#arXiv, @biorxivpreprint, and @medrxivpreprint have released their public comments on the the #OSTP #NelsonMemo.

From arXiv
https://info.arxiv.org/about/OSTP-04-11-2023.html

From bioRxiv and medRxiv
https://connect.biorxiv.org/news/2023/04/11/ostp_response

PS: There's a distinct echo of #Plan_U in these comments, tho without using the term. I'm glad to see it's still alive. Here's some background from 2019.
http://planu.org/

#bioRxiv, #medRxiv, #OAintheUSA, #preprints

@arxiv, @biorxivpreprint, and @medrxivpreprint have released their public comments on the #OSTP #NelsonMemo.

From arXiv
https://info.arxiv.org/about/OSTP-04-11-2023.html

From bioRxiv and medRxiv
https://connect.biorxiv.org/news/2023/04/11/ostp_response

PS: There's a distinct echo of #Plan_U in these comments, tho without using the term. I'm glad to see it's still alive. Here's some background from 2019.
http://planu.org/

#arXiv, #bioRxiv, #medRxiv, #OAintheUSA, #preprints

#arXiv, @biorxivpreprint, and @medrxivpreprint have released their public comments on the the #OSTP #NelsonMemo.

From arXiv
https://info.arxiv.org/about/OSTP-04-11-2023.html

From bioRxiv and medRxiv
https://connect.biorxiv.org/news/2023/04/11/ostp_response

PS: There's a distinct echo of #Plan_U in these comments, tho without using the term. I'm glad to see it's still alive. Here's some background from 2019.
http://planu.org/

#bioRxiv, #medRxiv, #OAintheUSA, #preprints

@arxiv, @biorxivpreprint, and @medrxivpreprint have released their public comments on the #OSTP #NelsonMemo.

From arXiv
https://info.arxiv.org/about/OSTP-04-11-2023.html

From bioRxiv and medRxiv
https://connect.biorxiv.org/news/2023/04/11/ostp_response

PS: There's a distinct echo of #Plan_U in these comments, tho without using the term. I'm glad to see it's still alive. Here's some background from 2019.
http://planu.org/

#arXiv, #bioRxiv, #medRxiv, #OAintheUSA, #preprints

"we review the scope and the role of preprint papers platforms in academia, we explore individual cases, #arXiv, #SSRN, #OSF Preprints, #HAL, #bioRxiv, #EconStor, #RePEc, #PhilArchive, Research Square, #viXra, Cryptology ePrint Archive, Preprints.org, #ChinaXiv, #medRxiv, #JMIR Preprints, #Authorea, #ChemRxiv, #engrXiv, e-LiS, #SciELO, #PsyArXiv, #F1000 Research, and #Zenodo,

...

2/

"we review the scope and the role of preprint papers platforms in academia, we explore individual cases, #arXiv, #SSRN, #OSF Preprints, #HAL, #bioRxiv, #EconStor, #RePEc, #PhilArchive, Research Square, #viXra, Cryptology ePrint Archive, Preprints.org, #ChinaXiv, #medRxiv, #JMIR Preprints, #Authorea, #ChemRxiv, #engrXiv, e-LiS, #SciELO, #PsyArXiv, #F1000 Research, and #Zenodo,

...

2/

"we review the scope and the role of preprint papers platforms in academia, we explore individual cases, #arXiv, #SSRN, #OSF Preprints, #HAL, #bioRxiv, #EconStor, #RePEc, #PhilArchive, Research Square, #viXra, Cryptology ePrint Archive, Preprints.org, #ChinaXiv, #medRxiv, #JMIR Preprints, #Authorea, #ChemRxiv, #engrXiv, e-LiS, #SciELO, #PsyArXiv, #F1000 Research, and #Zenodo,

...

2/

"we review the scope and the role of preprint papers platforms in academia, we explore individual cases, #arXiv, #SSRN, #OSF Preprints, #HAL, #bioRxiv, #EconStor, #RePEc, #PhilArchive, Research Square, #viXra, Cryptology ePrint Archive, Preprints.org, #ChinaXiv, #medRxiv, #JMIR Preprints, #Authorea, #ChemRxiv, #engrXiv, e-LiS, #SciELO, #PsyArXiv, #F1000 Research, and #Zenodo,

...

2/

Excited about this #Tourette treatment study extending the original work by Drs. Bàrbara Morera Màiquez & @jackson684. Median nerve stimulation #MNS improved tics during stimulation, but not via the originally proposed mechanism.

Peripheral nerve induction of inhibitory brain circuits to treat Tourette syndrome: A randomized crossover trial https://doi.org/10.1101/2023.02.01.23285304 #medRxiv @medrxivpreprint

We also completed an open-label follow-on study with an off-the-shelf TENS unit and #EMA ecological momentary assessments.
https://osf.io/n6f7q/

No evidence for link between #complement C4 and #schizophrenia!

An impressive #medRXiv study in ~70k blood samples fails to detect association between #C4 genes or protein at birth and schizophrenia later in life. This is interesting because the strongest genome-wide association for schizophrenia, found in the #MHC region, has so far been attributed to C4. May the search for other loci continue, I cannot wait to see the #GWAS mystery of schizophrenia unfold!

https://www.medrxiv.org/content/10.1101/2022.11.09.22281216v1